Search results for "Fertility-sparing"

showing 6 items of 6 documents

Reproductive and Obstetric Outcomes after Fertility-Sparing Treatments for Cervical Cancer: Current Approach and Future Directions

2023

Cervical cancer is one of the leading causes of cancer-related death in women of reproductive age. The established fertility-sparing approaches for the management of early-stage cervical cancer for women who plan pregnancy are associated with a decline in fecundity and an increased risk of pregnancy complications. This article aims to offer an overview of fertility-sparing approaches and the management of potential subfertility and pregnancy complications after these treatments. An extensive search for the available data about infertility and cervical cancer, fertility-sparing techniques in patients with cervical cancer, fertility treatment, obstetrical complications, and pregnancy outcomes…

Fertility-sparing surgeryPregnancy outcome.InfertilityCervical cancerObstetrical complicationGeneral MedicineSettore MED/40 - Ginecologia E OstetriciaJournal of Clinical Medicine
researchProduct

Sarcoma Botryoides: Optimal Therapeutic Management and Prognosis of an Unfavorable Malignant Neoplasm of Female Children

2023

Embryonal rhabdomyosarcoma (ERMS) is a rare malignancy and occurs primarily in the first two decades of life. Botryoid rhabdomyosarcoma is an aggressive subtype of ERMS that often manifests in the genital tract of female infants and children. Due to its rarity, the optimal treatment approach has been a matter of debate. We conducted a search in the PubMed database and supplemented it with a manual search to retrieve additional papers eligible for inclusion. We retrieved 13 case reports and case series, from which we summarized that the current trend is to approach each patient with a personalized treatment plan. This consists of a combination of local debulking surgery and adjuvant or neoad…

Clinical BiochemistryEmbryonal rhabdomyosarcoma Fertility-sparing surgery Genital tract Local debulking Neoadjuvant chemotherapy Prognosis Radiation Sarcoma botryoides TreatmentSettore MED/40 - Ginecologia E OstetriciaDiagnostics
researchProduct

Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis

2023

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study (Clinical Trial ID: NCT05791838) aimed to report a retrospective analysis of the management and outcomes of 86 consecutive BOTs patients, 54 of which were at a reproductive age. All patients with BOTs undergoing surgical treatment from January 2010 to December 2017 were included. Data were retrospectively reviewed. High levels of Ca-125 were observed in 25.6% of the FIGO stage I patients and 58.3% of the advanced disease patients. Fertility-sparing surgery and comprehensive surgical staging were performed in 36.7% and 4…

Fertility-sparing surgeryBorderline ovarian tumorSurgical staging.Conservative surgeryMicropapillary patternSettore MED/40 - Ginecologia E Ostetricia
researchProduct

Fertility-Sparing Strategies for Early-Stage Endometrial Cancer: Stepping towards Precision Medicine Based on the Molecular Fingerprint

2023

Endometrial cancer represents the fifth most common cancer in women, and the most common gynecological malignancy in developed countries [...]

Inorganic ChemistryEndometrial cancerFertility-sparingOrganic ChemistryGeneral MedicinePhysical and Theoretical ChemistryMolecular BiologySettore MED/40 - Ginecologia E OstetriciaSpectroscopyCatalysisComputer Science Applications
researchProduct

Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.

2022

Total hysterectomy and bilateral adnexectomy is the standard treatment for atypical endometrial hyperplasia and early-stage endometrial cancer. However, the recommended surgical treatment precludes future pregnancy when these conditions are diagnosed in women in their fertile age. In these patients, fertility-sparing treatment may be feasible if the desire for childbearing is consistent and specific conditions are present. This review summarizes the available evidence on fertility-sparing management for atypical endometrial hyperplasia and early-stage endometrial cancer. Historically, oral progestins have been the mainstay of conservative management for atypical endometrial hyperplasia and …

fertility-sparing treatmentFertility PreservationGeneral MedicineConservative TreatmentSettore MED/40 - Ginecologia E OstetriciaMetforminEndometrial NeoplasmsProgestinGonadotropin-Releasing HormoneTreatment OutcomeRetrospective StudiePregnancyendometrial cancerEndometrial HyperplasiaHumansEndometrial NeoplasmFemaleendometrial atypical hyperplasiaProgestinsHumanRetrospective StudiesMedicina (Kaunas, Lithuania)
researchProduct

Uterine sarcomas: A critical review of the literature

2023

This review aims to provide a comprehensive description of surgical approaches for the management of uterine sarcomas. Uterine sarcomas are rare uterine neoplasms. Frequently, diagnosis is made after hysterectomy or myomectomy scheduled for presumed benign leiomyomas. The gold standard for surgical treatment of uterine sarcomas is hysterectomy with bilateral salpingo-oophorectomy. It is possible to adopt a fertility-sparing approach for those patients who wish to maintain their fertility. The role of pelvic lymphadenectomy is controversial; in fact, removal of lymph nodes is only recommended in the case of radiological suspicion of nodal involvement. Use of a morcellator is associated with …

Fertility-sparing surgeryMesenchymal tumourUterine sarcoma.Gynaecologic surgeryGynaecologic oncologySettore MED/40 - Ginecologia E Ostetricia
researchProduct